193 related articles for article (PubMed ID: 36722311)
1. Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study.
Le Moli R; Malandrino P; Russo M; Tumino D; Piticchio T; Naselli A; Rapicavoli V; Belfiore A; Frasca F
Endocrinol Diabetes Metab; 2023 Mar; 6(2):e406. PubMed ID: 36722311
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
[TBL] [Abstract][Full Text] [Related]
3. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
[TBL] [Abstract][Full Text] [Related]
4. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients.
Gullo D; Latina A; Frasca F; Le Moli R; Pellegriti G; Vigneri R
PLoS One; 2011; 6(8):e22552. PubMed ID: 21829633
[TBL] [Abstract][Full Text] [Related]
5. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
Solter D; Solter M
Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Parameters and Kidney Disorder in Type 2 Diabetes: Results from the METAL Study.
Chen Y; Zhang W; Wang N; Wang Y; Wang C; Wan H; Lu Y
J Diabetes Res; 2020; 2020():4798947. PubMed ID: 32337292
[TBL] [Abstract][Full Text] [Related]
7. Identification of Resistance to Exogenous Thyroxine in Humans.
Lacámara N; Lecumberri B; Barquiel B; Escribano A; González-Casado I; Álvarez-Escolá C; Aleixandre-Blanquer F; Morales F; Alfayate R; Bernal-Soriano MC; Miralles R; Yildirim Simsir I; Özgen AG; Bernal J; Berbel P; Moreno JC
Thyroid; 2020 Dec; 30(12):1732-1744. PubMed ID: 32498666
[No Abstract] [Full Text] [Related]
8. LEVOTHYROXINE REPLACEMENT IN OBESE HYPOTHYROID FEMALES AFTER TOTAL THYROIDECTOMY.
Glymph K; Gosmanov AR
Endocr Pract; 2016 Jan; 22(1):22-9. PubMed ID: 26437220
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
10. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.
Grani G; Tumino D; Ramundo V; Ciotti L; Lomonaco C; Armillotta M; Falcone R; Lucia P; Maranghi M; Filetti S; Durante C
J Endocrinol Invest; 2019 Dec; 42(12):1485-1490. PubMed ID: 31203497
[TBL] [Abstract][Full Text] [Related]
11. Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study.
Del Duca SC; Santaguida MG; Brusca N; Gatto I; Cellini M; Gargano L; Verga Falzacappa C; Frattaroli FM; Virili C; Centanni M
Eur J Endocrinol; 2015 Sep; 173(3):351-7. PubMed ID: 26092761
[TBL] [Abstract][Full Text] [Related]
12. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
[No Abstract] [Full Text] [Related]
13. Effects of Thyrotropin on Peripheral Thyroid Hormone Metabolism and Serum Lipids.
Beukhof CM; Massolt ET; Visser TJ; Korevaar TIM; Medici M; de Herder WW; Roeters van Lennep JE; Mulder MT; de Rijke YB; Reiners C; Verburg FA; Peeters RP
Thyroid; 2018 Feb; 28(2):168-174. PubMed ID: 29316865
[TBL] [Abstract][Full Text] [Related]
14. Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit.
Kozłowska L; Rosołowska-Huszcz D
Endocrine; 2004 Jul; 24(2):147-53. PubMed ID: 15347841
[TBL] [Abstract][Full Text] [Related]
15. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
Jonklaas J; Davidson B; Bhagat S; Soldin SJ
JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
[TBL] [Abstract][Full Text] [Related]
16. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
17. Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients.
Ito M; Miyauchi A; Kang S; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nakamura H; Amino N
Eur J Endocrinol; 2015 Sep; 173(3):333-40. PubMed ID: 26077156
[TBL] [Abstract][Full Text] [Related]
18. The dynamic pituitary response to escalating-dose TRH stimulation test in hypothyroid patients treated with liothyronine or levothyroxine replacement therapy.
Yavuz S; Linderman JD; Smith S; Zhao X; Pucino F; Celi FS
J Clin Endocrinol Metab; 2013 May; 98(5):E862-6. PubMed ID: 23585666
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
20. Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine.
Werneck de Castro JP; Fonseca TL; Ueta CB; McAninch EA; Abdalla S; Wittmann G; Lechan RM; Gereben B; Bianco AC
J Clin Invest; 2015 Feb; 125(2):769-81. PubMed ID: 25555216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
